Real-Time Motion Analysis Reveals Cell Directionality as an Indicator of Breast Cancer Progression
暂无分享,去创建一个
W. Losert | C. Parent | Michael Weiger | V. Vedham | C. Stuelten | Karen Shou | M. Herrera | Misako Sato
[1] P Rosen,et al. Cell density determines epithelial migration in culture. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[2] Jose Russo,et al. Human Breast Epithelial Cell Line, MCF-10 Isolation and Characterization of a Spontaneously Immortalized , 2006 .
[3] P. Friedl,et al. Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. , 1995, Cancer research.
[4] Stephen Pulman,et al. Building the Framework , 1996 .
[5] F. Miller,et al. MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.
[6] T. Beckers,et al. Overexpression of EGFR and c‐erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts , 1998, FEBS letters.
[7] D. Stern. Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases , 2000, Breast Cancer Research.
[8] A. Ramaioli,et al. Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Alan Wells,et al. Growth Factor-Induced Cell Motility in Tumor Invasion , 2002, Acta oncologica.
[10] G. Mills,et al. The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.
[11] P. Friedl,et al. Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.
[12] L. Wakefield,et al. TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression , 2003 .
[13] D. Im,et al. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. , 2003, Molecular pharmacology.
[14] L. Wakefield,et al. The two faces of transforming growth factor beta in carcinogenesis. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Wakefield,et al. The two faces of transforming growth factor β in carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[16] Donna J. Webb,et al. New dimensions in cell migration , 2003, Nature Cell Biology.
[17] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[18] C. J. Barnes,et al. Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets , 2003, Cancer and Metastasis Reviews.
[19] Fred R. Miller,et al. Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.
[20] P. Clézardin,et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. , 2004, The Journal of clinical investigation.
[21] C. J. Barnes,et al. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells , 2004, Clinical Cancer Research.
[22] Erik Sahai,et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.
[23] J. Pfeilschifter,et al. The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7. , 2005, Biochimica et biophysica acta.
[24] Timothy J Mitchison,et al. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. , 2005, Chemistry & biology.
[25] S. Steinberg,et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. , 2005, Journal of the National Cancer Institute.
[26] J. McCubrey,et al. EGF Induces Cell Motility and Multi-Drug Resistance Gene Expression in Breast Cancer Cells , 2006, Cell cycle.
[27] P. Clézardin,et al. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[28] Stanislav Y Shvartsman,et al. Role of boundary conditions in an experimental model of epithelial wound healing. , 2006, American journal of physiology. Cell physiology.
[29] A. Rajasekaran,et al. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. , 2006, Cancer research.
[30] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[31] Jeffrey Wyckoff,et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. , 2006, Cancer research.
[32] E. Sahai,et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.
[33] P. Chavrier,et al. Collective migration of an epithelial monolayer in response to a model wound , 2007, Proceedings of the National Academy of Sciences.
[34] Min Chen,et al. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. , 2007, American journal of physiology. Cell physiology.
[35] Alan Wells,et al. EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation , 2007, Journal of Cell Science.
[36] Anastasia Khvorova,et al. Identification of genes that regulate epithelial cell migration using an siRNA screening approach , 2008, Nature Cell Biology.
[37] D. Lauffenburger,et al. A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. , 2008, Developmental cell.
[38] N. Marella,et al. Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines. , 2009, Cancer research.
[39] Yiling Lu,et al. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. , 2009, Cancer cell.
[40] James I. Fells,et al. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. , 2009, Cancer research.
[41] G. Mills,et al. β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor Cells , 2009, Molecular Cancer Research.
[42] Erik Sahai,et al. Localised and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility , 2009, Nature Cell Biology.
[43] P. Friedl,et al. Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.
[44] I. Takeyoshi,et al. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites. , 2009, Carcinogenesis.
[45] P. Friedl,et al. The Journal of Cell Biology , 2002 .
[46] M. Poujade,et al. Velocity fields in a collectively migrating epithelium. , 2010, Biophysical journal.
[47] Kyoko Noguchi,et al. LPA receptors: subtypes and biological actions. , 2010, Annual review of pharmacology and toxicology.
[48] Mitsutaka Kadota,et al. Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines , 2010, PloS one.
[49] S. Lipkowitz,et al. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. , 2010, Breast disease.
[50] Jun Du,et al. Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling , 2010, PloS one.
[51] Graeme I Murray,et al. Current and emerging concepts in tumour metastasis , 2010, The Journal of pathology.
[52] Akira Oshima,et al. Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer , 2010, PloS one.
[53] G. Mills,et al. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression , 2010, British Journal of Cancer.
[54] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[55] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[56] J Downward,et al. An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis , 2011, Oncogene.
[57] King-Jen Chang,et al. Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis , 2011, PloS one.
[58] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[59] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[60] R. Gomis,et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. , 2012, The Journal of clinical investigation.
[61] Alan Wells,et al. 2D protrusion but not motility predicts growth factor–induced cancer cell migration in 3D collagen , 2012, The Journal of cell biology.
[62] J. Käs,et al. Directed persistent motion maintains sheet integrity during multi-cellular spreading and migration , 2012 .
[63] O. Kallioniemi,et al. Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models , 2011, Oncogene.
[64] Martin Krapcho,et al. SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .
[65] A. Sigal,et al. Collective and single cell behavior in epithelial contact inhibition , 2011, Proceedings of the National Academy of Sciences.
[66] C. Sotiriou,et al. Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions , 2012, Oncogene.
[67] Stephen T C Wong,et al. Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis , 2012, Cancer.
[68] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[69] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .